Orion Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.43M | Sell |
|
|||||
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $902K | Hold |
|
|||||
|
2024
Q4 | $786K | Sell |
|
|||||
|
2024
Q3 | $942K | Sell |
|
|||||
|
2024
Q2 | $869K | Sell |
|
|||||
|
2024
Q1 | $549K | Hold |
|
|||||
|
2023
Q4 | $703K | Hold |
|
|||||
|
2023
Q3 | $651K | Sell |
|
|||||
|
2023
Q2 | $755K | Hold |
|
|||||
|
2023
Q1 | $796K | Sell |
|
|||||
|
2022
Q4 | $952K | Sell |
|
|||||
|
2022
Q3 | $836K | Sell |
|
|||||
|
2022
Q2 | $855K | Sell |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $1.13M | Sell |
|
|||||
|
2021
Q3 | $1.26M | Hold |
|
|||||
|
2021
Q2 | $1.13M | Hold |
|
|||||
|
2021
Q1 | $942K | Hold |
|
|||||
|
2020
Q4 | $868K | Buy |
|